Probiotics and osteoporosis: review reports changes in bone markers
The reported changes concerned markers of bone formation and breakdown. The abstract does not show that supplementation prevented fractures.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
Across the included trials, probiotic supplementation was associated with increases in markers of bone formation and decreases in markers of bone breakdown. These laboratory results address bone turnover, the review's main question. They do not demonstrate fewer fractures or establish which probiotic product offers a meaningful health benefit for people with osteoporosis.
This abstract-based account lacks control-group details and evidence-certainty ratings. The authors call for longer trials and research on individual strains before clinical usefulness can be confirmed.
Markers were the measured outcomes
Markers linked to bone formation rose, including P1NP, while the bone-breakdown marker CTX-I fell. These are biochemical findings; the abstract's suggestion of lower fracture risk is not backed by reported fracture outcomes.
Subgroup findings need detail
The authors reported larger marker changes in postmenopausal women than in mixed-gender groups, alongside differences by strain mixture and dose. Without detailed subgroup estimates, these findings cannot establish a preferred product, dose or patient group.
The original publication
Meta-analysis of the effects of probiotic supplementation on bone turnover markers in middle-aged and elderly patients with osteoporosis.
Yuan Y, Li J, Wang K et al.
Front Cell Infect Microbiol · 2025
- PubMed ID
- 41574289
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.